Maffeis, Claudio http://orcid.org/0000-0002-3563-4404
Busetto, Luca
Wasniewska, Malgorzata
Di Pauli, Daniele
Maccora, Carla http://orcid.org/0000-0002-3384-6606
Lenzi, Andrea
Clinical trials referenced in this document:
Documents that mention this clinical trial
Insights from the ACTION Teens Study: a survey of adolescents living with obesity, their caregivers and healthcare professionals in the UK
https://doi.org/10.1136/bmjopen-2024-086391
Perceptions, attitudes, and behaviors among adolescents living with obesity, caregivers, and healthcare professionals in Italy: the ACTION Teens study
https://doi.org/10.1007/s40519-024-01663-7
Funding for this research was provided by:
Novo Nordisk A/G
Article History
Received: 13 March 2024
Accepted: 22 April 2024
First Online: 8 May 2024
Declarations
:
: ACTION Teens was conducted in compliance with the Declaration of Helsinki. In Italy, approval was granted by the Ethics Committee for Clinical Trials at Integrated University Hospital Verona (Verona, Italy) on August 9, 2021 (Protocol number: 46600).
: Respondents (plus parents/legal guardians of ALwO) gave informed consent to participate.
: Claudio Maffeis received consultancy fees from Novo Nordisk for his role as a member of the ACTION Teens Steering Committee during the conduct of the study; he also reports honoraria (for lectures) from Aboca, Eli Lilly, Novo Nordisk, Roche, and Sanofi, and participation in advisory boards for Abbott, Eli Lilly, Medtronic, and Sanofi outside the submitted work. Luca Busetto reports honoraria (for lectures) from PronoKal and Rhythm Pharmaceuticals, and participation in advisory boards for Bruno Farmaceutici, Eli Lilly, Novo Nordisk, and Pfizer outside the submitted work. Malgorzata Wasniewska is a consultant for Merck, Novo Nordisk, Pfizer, and Sandoz. Daniele Di Pauli and Andrea Lenzi have no relevant financial/non-financial interests to disclose. Carla Maccora is a permanent employee of Novo Nordisk.